MedTrace Logo

Molecular Signature Pregnancy

NCT02797327 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 430

Last updated 2023-10-18

No results posted yet for this study

Summary

The primary goal of the study is to identify biomarkers from the molecular signature predictive of pre-term birth. This will be achieved through high frequency sampling and profiling throughout pregnancy.

Conditions

  • Pregnancy

Sponsors & Collaborators

  • Sidra Medicine

    collaborator OTHER

  • University of Oxford

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-12
Primary Completion
2023-01-30
Completion
2023-01-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02797327 on ClinicalTrials.gov